alysis within 2 years of access surgery, suggesting that nephrologists are appropriately incorporating patient age in determining the optimal timing of referral of elderly patients for predialysis permanent VA placement [1] . Because elderly patients with high cardiovascular comorbidity are also more likely to die before the initiation of dialysis, deferring VA creation in elderly patients with cardiovascular comorbidity has been suggested. Deaths in patients with CKD are largely driven by cardiovascular comorbidity [2, 3] . However, in the last decade between 2000 and 2010, there has been a substantial decline in cardiovascular mortality observed in both the general adult population and in the hemodialysis population in the United States [4, 5] . The goal of the current study was to investigate whether there was a parallel improvement in cardiovascular comorbidity among a select group of elderly patients with CKD undergoing predialysis access surgery, and whether this trend affected the likelihood of dying before initiating dialysis, survival without initiating dialysis, or initiating dialysis during 2 years of follow-up after VA surgery. To evaluate these questions, we used a large representative US population of elderly CKD patients undergoing predialysis VA creation between 2004 and 2009, and divided them into 3 time cohorts (2004-2005, 2006-2007 and 2008-2009 ). For each temporal cohort, we assessed the cardiovascular comorbidities and cardiovascular events prior to VA surgery, as well as cardiovascular events occurring in the first year after dialysis initiation.
Methods

Data Sources and Study Population
A waiver from the University of Alabama at Birmingham Investigational Review Board was obtained before initiating data analysis. Patient consent was not obtained for this study, as all information utilized for this study were from national administrative claims data from a random sample of 5% Medicare patients with CKD and data from the United States Renal Data System (USRDS). Center for Medicare and Medicaid Services rules allow for the release of limited data sets with a data use agreement executed with the USRDS coordinating center. Data source and patient exclusion criteria were described in detail in our previous paper [1] . To summarize, we identified 3,418 Medicare patients aged 70 and older with an incident VA created before dialysis between January 1, 2004 and December 31, 2009 from using a Medicare 5% sample CKD-based cohort [1] . Our cohort consisted of patients 70 years and older in order to allow for a 5-year baseline before the index date (similar to one used by Oliver et al. [6] ) to ensure a first predialysis VA surgery and to collect complete severity of illness and comorbidity information. Specifically, the CKD patient, physician/supplier, and institutional claims were used to obtain hospitalization, surgery, comorbidities, and outpatient encounters. A 5-year baseline prior to the index date (similar to one used by Oliver et al. [6] ) was used to ensure an incident VA surgery and to collect severity of illness and comorbidity information. Patients were followed from incident VA creation until initiation of dialysis, death or end of 2-year follow-up.
Variables of Interest
Patient demographics (age, gender and race) were determined from CKD-based cohort patient file. Comorbidities were determined by 1 inpatient diagnosis code (either primary or secondary) and/or 2 outpatient diagnosis codes in the year prior to the index date and included diabetes, cancer, ischemic heart disease, chronic obstructive pulmonary disease, peripheral vascular disease (PVD), cerebral vascular disease, depression, dementia, and amputation. Cardiovascular comorbidities (e.g. stroke, myocardial infarction (MI) and congestive heart failure (CHF)) were identified based on a primary reason for hospitalization during the baseline year. Comorbidities were selected based upon published literature indicating a substantial influence on mortality among late stage CKD patients [7, 8] . We used a comorbidity index developed and validated for dialysis patients, which outperformed the more widely used Charlson comorbidity index in both predictive ability and inference [9] [10] [11] .
Statistical Analysis
The baseline demographic and clinical characteristics of 3 temporal cohorts (2004-2005, 2006-2007 and 2008-2009 ) were summarized as frequency (percentage) for categorical data and mean ± SD for numeric data. To evaluate potential differences in medical care received by patients across the 3 time periods, we calculated outpatient physician and nephrologist visits and hospitalizations per patient-time. We further linked the 3 temporal cohorts of CKD patients to USRDS Medical Evidence Form to identify patients who initiated dialysis within 2 years of VA creation. These patients were followed from dialysis initiation for 1 year to calculate a composite end-point of death or cardiovascular events, or the end of follow-up. Patients' acute cardiovascular events including CHF, MI, and stroke were obtained from USRDS institutional claims by using International Classification of Disease-9 codes as follows: CHF ('402x1', '404x1', '404x3', '422', '425', '428', and 'V421'), MI ('410'), and stroke ('430' to '434'). Survival at 180 and 360 days after dialysis initiation was examined using Kaplan-Meier survival curves and compared across 3 time periods. A composite endpoint of a cardiovascular event or mortality, whichever came first, was also calculated. All the analyses were conducted by SAS version 9.2.
Results
Temporal Trends in Patient Characteristics and Comorbidities
During the 6-year period between January 1, 2004 and December 31, 2009, 3,418 elderly (age ≥ 70) CKD patients from the 5% Medicare sample received an AVF or AVG before initiating dialysis ( table 1 ). The mean age of study patients was 78.0. A majority of patients were male (54.0%) and white (74.7%), and a substantial proportion had diabetes (66.2%), ischemic heart disease (64.6%), PVD (63.4%) and CHF (40.6%). Among elderly patients who received a predialysis VA, there was a progressive decrease in patients with history of PVD (from 66.5 to 59.7%, p < 0.005), CHF (from 47.0 to 35.8%, p < 0.005) and MI (from 6.5 to 3.3%, p < 0.001) between the 3 time cohorts (2004-2005, 2006-2007 and 2008-2009 ). The decrease in cardiovascular comorbidities in the 3 time periods was greater in patients age >80 than in those aged 70-80. Specifically, the relative decrease in stroke (40 vs. 10%), MI (52 vs. 47%) and CHF (26 vs. 23%) and comorbidity score (10 vs. 1%) was consistently greater in the older patient cohort ( table 1 a). All other demographics and comorbidities were similar between the 3 time cohorts ( table 1 ) .
Temporal Trends in Clinical Outcomes before Initiation of Hemodialysis
During the 3 consecutive time periods (2004-2005, 2006-2007 and 2008-2009 ), the proportion of elderly patients dying before initiating hemodialysis decreased from 17.5 to 12.6%, the proportion surviving without hemodialysis increased from 14.5 to 19.0% and the proportion initiating hemodialysis remained constant at ∼ 68% (p < 0.001; table 2 ). We also evaluated rates of hospitalization and outpatient visits per patient-year among elderly CKD patients after predialysis VA was placed. Overall, there was no difference in rates of hospitalization, outpatient physician visits or nephrology visits between the 3 time cohorts (data not shown). Cohort was followed for 2 years after first VA insertion until death, initiation of dialysis or end of follow-up. For continuous variable, values presented as mean and SD; for categorical variable, values in column 2 are number of patients and percent of the total study cohort of the year. COPD = Chronic obstructive pulmonary disease. 
in patient mortality at 180 and 360 days after initiation of dialysis between the 3 time periods. However, mortality differences were evident when the patients were subdivided into 2 age ranges; the 1-year mortality decreased by a nonsignificant 3% in patients aged 70-80 years, but decreased by 27% in those >80 years fig. 1 a) . When stratified by age categories 70-80 ( fig. 1 b) and >80 ( fig. 1 c) , only age >80 demonstrated substantially reduced incidence of death or cardiovascular event (HR 0.74, 95% CI 0.56-0.97; p = 0.03).
Discussion
We have identified a trend over a 6-year period (from 2004 to 2009) of improving cardiovascular comorbidity among a select group of elderly CKD patients undergoing predialysis VA that was reflected in a smaller proportion of patients with a history of PVD, heart failure or MI. In our study, this trend seemed to be driven by the improved cardiovascular outcomes in patients age >80. To our knowledge, secular changes in cardiovascular health have not been previously reported among the CKD predialysis population. As one might expect, the lower cardiovascular comorbidities in this population translated into improved clinical outcomes after access creation, namely, fewer patients dying before dialysis and more patients surviving without requiring initiation of dialysis.
What might account for such a large improvement in the cardiovascular comorbidities of this population over a relatively short time period? The most likely explanation is that the improvement in cardiovascular comorbidities among elderly CKD patients undergoing predialysis access surgery simply mirrors that trend observed in the overall US population. Cardiovascular mortality declined by 30.8% from 2001 to 2011 among the general adult US population, a change that has been attributed to smoking cessation, better blood pressure control and more widespread use of statins [4] . There was a similar Values presented as number of patients and row percentage in parenthesis. p < 0.001 for full cohort; p = 0.01 for age 70-80 years; p = 0.11 for age >80 indicating differences between all 3 time periods. [12] . In our study, we observed a 17% reduction in risk of death or CV events in the first year of dialysis. In fact, our study suggests that the most significant improvement in the incidence of death or cardiovascular event in the first year of hemodialysis decreased substantially from 2004-2005 to 2008-2009 in the most elderly patients, that is those patients age >80. We also postulated that better medical care in the current study population would be reflected in more frequent outpatient physician visits (with nephrologists or other physicians) or less frequent hospitalizations after undergoing VA surgery. This hypothesis was not supported by our data. However, our database does not include more specific medical interventions prescribed during these visits or hospitalizations (e.g. blood pressure control, use of ACE inhibitors or ARBs, diabetic control, prescription of statins).
A less likely explanation for the improvement of cardiovascular comorbidities among elderly CKD patients undergoing predialysis access surgery is that nephrologists are preferentially referring for predialysis access surgery to those patients with less cardiovascular morbidity. Testing this hypothesis would require a comparison of cardiovascular comorbidity in elderly CKD patients with and without predialysis access surgery. Unfortunately, the database we utilized lacks information about kidney function. As a consequence, we did not have a suitable control group. Furthermore, supportive care may be another issue for not considering preemptive access in elderly advanced CKD patients. In recent years, there has been a concerted emphasis on patient-centered and shared decision making for our elderly advanced CKD patients [13] [14] [15] , which may impact our thought process when considering preemptive VA placement in this group. In other words, because dialysis may not confer survival benefit in certain groups of elderly patients with comorbid conditions, excluding them from consideration for preemptive VA placement is a reasonable approach.
A number of previous studies have reported that patients with advanced CKD are significantly more likely to die than to reach ESRD and initiate dialysis during follow-up after a VA surgery [16] [17] [18] . The likelihood of dying before reaching ESRD and not initiating dialysis is particularly high in elderly patients with CKD, and still higher in those with substantial cardiovascular comorbidity [16] . However, the more likely a patient is to die before reaching ESRD and not in need of dialysis, the 339 more compelling the justification for withholding predialysis access surgery. If elderly CKD patients are progressively having less cardiovascular comorbidities, it may be that a larger proportion should appropriately be considered for predialysis access surgery, as they are less likely to die before progressing to the need for hemodialysis. A major strength of this study is the use of a nationally representative random sample of elderly patients with advanced CKD. This allows one to generalize the findings with a high degree of confidence to individual medical centers. Our study also has several limitations. First, we do not have information on the total number of elderly patients potentially eligible for predialysis access surgery, and so we cannot examine temporal changes in CVD for patients not selected for VA surgery. Second, we do not have documentation of the reason that a particular elderly patient with CKD was not referred for predialysis access surgery. Thus, we can only infer that the nephrologist or surgeon deemed a given patient to be a poor candidate for predialysis access surgery. However, there may be alternative reasons, such as patient refusal to undergo access surgery prior to starting dialysis. In the first 2 reasons discussed above, selection bias may be a possible explanation for improved level of cardiovascular comorbidities in elderly patients receiving preemptive permanent access. However, data from the National Heart, Lung, and Blood Institute have shown a steady decline in age-adjusted death rates for cardiovascular disease in the general medical population in the United States during the time period of our cohort [19] . While the data do not specifically pertain to that of elderly CKD patients, we may also be seeing a similar trend in this population. Finally, our data are limited to a period of 6 years, and we do not know whether the trends described in this study began prior to 2004 or continued after 2009. If, in fact, the progressive improvements in cardiovascular comorbidities continued after 2009, as was the case among the general US population [4, 19] , this lends enhanced credence to our conclusion that more elderly patients should be deemed eligible for VA surgery before dialysis.
Conclusions
In conclusion, the observations in this study show that among elderly patients with advanced CKD patients undergoing predialysis VA placement, the cardiovascular comorbidities has decreased progressively from 2004 to 2009. Consequently, these patients are now less likely to die before dialysis initiation, more likely to survive without ESRD, and equally likely to start HD within 2 years of access surgery. Because they are healthier, these patients are also less likely to have cardiovascular events after starting dialysis. These insights should be translated into more thoughtful consideration of which elderly patients should undergo predialysis access surgery. Thus, our observations from this study suggest that for a select group of elderly CKD patients without significant cardiovascular comorbidities, increased placement of predialysis VA may be warranted.
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